National Drug Schedules

including but not limited to abiraterone acetate

for human use

when recommended for administration by intravenous injection

When sold in oral, fixed-dose combinations, in package sizes containing 20,000 mg or less of acetaminophen and 6,000 mg or less of ibuprofen*
*Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription

When sold in oral, fixed-dose combinations, in package sizes containing either more than 20,000 mg of acetaminophen or more than 6,000 mg of ibuprofen*
*Note that this listing does not apply to products containing ibuprofen that would meet the criteria to be included on the Prescription Drug list, as these would require a prescription

up to and including 650 mg per unit, in package sizes containing no more than 50 units

in strengths of greater than 650 mg per unit or in package sizes of more than 50 units

for human use

including but not limited to adefovir dipivoxil

when sold or recommended for administration by intravenous injection

for human use including but not limited to: Betamethasone valerate, betamethasone sodium, betamethasone phosphate, betamethasone dipropionate, budesonide, ciclesonide, clobetasone, cortisone, dexamethasone sodium, dexamethasone phosphate, dexamethasone acetate, difluprednate, fludrocortisone acetate, flunisolide, fluticasone propionate, fluticasone furoate, hydrocortisone acetate, hydrocortisone aceponate, hydrocortisone sodium, methylprednisolone acetate, methylprednisolone, methylprednisolone succinate, methylprednisolone sodium, mometasone furoate, prednisolone acetate, prednisolone sodium, prednisolone phosphate, prednisone, triamcinolone acetonide, triamcinolone hexacetonide except: (a) hydrocortisone or hydrocortisone acetate, when sold as a single medicinal ingredient in a concentration that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (b) hydrocortisone or hydrocortisone acetate, when sold in combination with any other nonprescription medicinal ingredient that provides 1.0% or less hydrocortisone in preparations for topical use on the skin; or (c) clobetasone butyrate when sold in a concentration of 0.05% in cream preparations for topical use on the skin; or (d) triamcinolone acetonide in a nasal spray that delivers 55 microgram (mcg)/spray for those 12 years of age and older; or, (e) mometasone furoate for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 12 years of age and older; or (f) fluticasone propionate for the treatment of allergic rhinitis in a nasal spray that delivers 50 microgram/spray for those 18 years of age and older.

including but not limited to citric acid, glycolic acid, lactic acid, malic acid, mandelic acid, ammonium glycolate, glycolic acid + ammonium glycolate, alpha-hydroxyethanoic acid + ammonium alpha-hydroxyethanoate, alpha-hydroxyoctanoic acid, alpha-hydroxycaprylic acid, hydroxycaprylic acid, mixed fruit acid, triple fruit acid, tri-alpha hydroxy fruit acids, alpha hydroxy and botanical complex, l-alpha hydroxy acid, glycomer in cross-linked fatty acids alpha nutrium, when sold in topical formulations containing alpha hydroxy acids alone or in combination at concentrations of greater than 30% and/or with a pH lower than 3.0, except when sold to be applied to warts, corns or calluses

including but not limited to alfaxalone, alphaxolone

including but not limited to tenecteplase

Including: Dimethylaminodiphenylbutanonitrile; Dipipanone; Isomethadone; Methadone; Normethadone; Norpipanone; Phenadoxone
 

PDL, including but not limited to amikacin sulfate

for human use

Including 4-Methylaminorex and 4,4'-Dimethylaminorex.

including but not limited to mesalazine

including but not limited to dronedarone

Excluding those substances set out in item 1 of Part I of the schedule to Part J (of the Food and Drug Regulations) but including: amphetamine; methamphetamine; Benzphetamine 

including but not limited to fosamprenavir

for human use

Including: Diampromide, Phenampromide,  Propiram
 

Including: Androisoxazole; Androstanolone; Androstenediol; Bolandiol; Bolasterone; Bolazine; Boldenone; Bolenol; Calusterone; Clostebol; Drostanolone; Enestebol; Epitiostanol; Ethylestrenol; 4-Hydroxy-19-nor testosterone; Fluoxymesterone; Formebolone; Furazabol; Mebolazine; Mesabolone;  Mesterolone;  Metandienone;  Metenolone; Methandriol; Methyltestosterone; Metribolone; Mibolerone; Nandrolone; Norboletone; Norclostebol;  Norethandrolone; Oxabolone; Oxandrolone; Oxymesterone; Oxymetholone; Prasterone; Quinbolone; Stanozolol; Stenbolone; Testosterone; Tibolone; Tiomesterone; Trenbolone

for human use, except preparations for topical use

except otic preparations

for otic use

including but not limited to fosaprepitant

including but not limited to asenapine maleate

when sold for administration by injection

including but not limited to atropine sulphate, in ophthalmic or parenteral preparations

including but not limited to ivermectin, selamectin, doramectin for human use

For veterinary use - including but not limited to Ivermectin, selamectin, doramectin.  Ivermectin when when recommended for intramuscular injection for horses or for oral administration to dogs and cats, except doramectin. 

including but not limited to azatadine

Including but not limited to Bacillus Calmette-Guérin (BCG): Strain TICE, Strain Russian BCG-I, when sold or recommended as an antineoplastic agent.

For veterinary use

For human use: for parenteral use

For human use: for topical use

For human use: for ophthalmic use

Excluding the substances set out in items 6 and 7 of Part I of this schedule (Schedule G of the Food and Drug Regulations), as well as barbituric acid and its salts and 1,3-dimethylbarbituric acid and its salts, but including: Allobarbital; Alphenal; Amobarbital; Aprobarbital; Barbital; Butabarbital; Butalbital; Butallylonal; Butethal; Cyclobarbital; Cyclopal; Heptabarbital; Hexethal; Hexobarbital; Mephobarbital; Methabarbital; Methylphenobarbital; Propallylonal;
Phenobarbital; Probarbital; Phenylmethylbarbituric Acid; Sigmodal; Talbutal; Vinbarbital; Vinylbital
 

For veterinary use

including but not limited to benazepril hydrochloride

including but not limited to bendamustine hydrochloride

Including: Phenazocine, Metazocine, Pentazocine; but not including: Cyclazocine and its salts
 

Including: Clonitazene, Etonitazene 
 

Including: Alprazolam, Bromazepam, Brotizolam, Camazepam, Chlordiazepoxide, Clobazam, Clonazepam, Clorazepate, Cloxazolam, Delorazepam, Diazepam, Estazolam, Ethyl Loflazepate, Fludiazepam, Flurazepam, Halazepam, Haloxazolam, Ketazolam, Loprazolam, Lorazepam, Lormetazepam, Medazepam, Midazolam, Nimetazepam, Nitrazepam, Nordazepam, Oxazepam, Oxazolam, Pinazepam, Prazepam, Quazepam, Temazepam, Tetrazepam,  Triazolam; but not including: Clozapine and any salt thereof, Flunitrazepam and any salts or derivatives thereof, Olanzapine and its salts, Clozapine N-oxide and its salts

in concentrations greater than 5% or when sold in combination with another medicinal ingredient

including but not limited to benzatropine

for human use, when sold or recommended for the treatment of homocystinuria

for veterinary use

when sold in strengths of 5mg or less per oral dosage unit, in package sizes containing no more than 105 mg of bisacodyl

when sold in strengths of 10mg or less per rectal dosage unit/suppository, in package sizes containing no more than 50mg of bisacodyl

(except when sold in strengths of 5mg or less per oral dosage unit in package sizes containing no more than 105mg of bisacodyl and except when sold in strengths of 10mg or less per rectal dosage unit/suppository in package sizes containing no more than 50mg of bisacodyl)

including but not limited to Bosutinib methanoate

including but not limited to onabotulinumtoxin A, incobotulinumtoxin A, abobotulinumtoxin A, rimabotulinumtoxin B, prabotulinumtoxin A

including but not limited to candesartan cilexetil

Including but not limited to: Doripenem, ertapenem, imipenem, meropenem

When used in combination with another drug. 

Including but not limited to: Cephalexin (cefalexin), cephapirin (cefapirin), cefaclor, cefadroxil, cefazolin, cefonicide, cefoxitin, cefprozil, cefuroxime, loracarbef, cefdinir, cefixime, cefoperazone, cefotaxime, cefpodoxime proxetil, ceftazidime, ceftibuten, ceftriaxone, cefepime, ceftobiprole, ceftolozane, cefovecin, ceftiofur

see hydroxyzine or its salts or derivatives

in concentrations of 10mg equivalent to 8.5mg or less of cetirizine base per dosage unit) in products marketed for adult use (age 12 and over)

Clofedanol.

except in preparations for external use

for human use when used as a topical oral preparation

for human use

for human use

For veterinary use

for human use

when sold in combination with magnesium salicylate

For veterinary use

for veterinary use

except when sold in concentrations of 200 milligrams or less per oral dosage unit and indicated for the treatment of heartburn

when sold in concentrations of 100 mg or less per dosage unit and indicated for the treatment of heartburn

for veterinary use, including but not limited to closantel sodium

for human use, except in preparations for topical or vaginal use

for human use in preparations for intra-vaginal use

Including: Coca leaves; Cocaine; Ecgonine; but not including 123l-ioflupane
 

including but not limited to colesevelam hydrochloride

including but not limited to colistimethate

when recommended for the debridement of severe burns and skin ulcers

except sodium cromoglicate (cromoglycate) in solutions for ophthalmic or nasal use in concentrations of 2% or less [*see sodium cromoglicate (cromoglycate)]

for human use

in preparations for parenteral or ophthalmic use, except when sold for use in diagnostic procedures to an optometrist registered in a province of Canada

including but not limited to ciclosporin

including but not limited to cyproterone acetate

including but not limited to dabigatran etexilate

when used in an injectable form

when sold for the treatment of bacterial vaginosis

for veterinary use

in products marketed for adult use - 12 years and older

including but not limited to desvenlafaxine succinate

for veterinary use

when sold as a single medicinal ingredient for topical use on the skin for not more than 7 days - in concentrations greater than 1.16% and less than or equal to 2.32% - in package sizes containing no more than 2.6g of diclofenac diethylamine

when sold as a single medicinal ingredient for topical use on the skin in concentrations of not more than 1.16% for not more than 7 days

including (but not limited to): diclofenac diethylamine, diclofenac sodium, diclofenac potassium, except when sold as a single medicinal ingredient for topical use on the skin in a concentration equivalent to 2% or less of diclofenac for not more than 7 days

ovine

For human use

for human use

except in preparations for topical use on the skin

for topical use on the skin

For veterinary use

For human use, when sold for the treatment of interstitial cystitis or scleroderma

For human use

including but not limited to cabazitaxel

when sold for administration by injection

including but not limited to doxycycline hyclate, doxycycline monohydrate

except those sold for nausea and vomiting of pregnancy

when sold or recommended for use in the nausea or vomiting of pregnancy

including but not limited to eltrombopag olamine

including but not limited to emamectin benzoate

including but not limited to enalapril maleate

in preparations containing more than 8 mg per unit dose, or with a label recommending more than 8 mg/dose or 32 mg/day, or labelled or implied for use exceeding 7 days, or if indicated for other than nasal congestion.

for human use

including but not limited to eribulin mesylate

Including but not limited to: azithromycin, clarithromycin, gamithromycin, telithromycin, tulathromycin

including but not limited to erythropoietin, darbepoetin alpha, epoetin alfa

for veterinary use

For human use, when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of esomeprazole

For human use, including but not limited to esomeprazole magnesium, EXCEPT when sold for the 14-day treatment for frequent heartburn at a daily dose of 20 mg, in package sizes of no more than 280 mg of esomeprazole

For human use - when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing more than 600 mg of famotidine.

For human use - when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn, in package sizes containing no more than 600 mg of famotidine.

For veterinary use.

For human use - except when sold in concentrations of 20 mg or less per oral dosage unit and indicated for the treatment of heartburn.

Including but not limited to dexfenfluramine.

Including: Acetyl-α-methylfentanyl, Alfentanil, Carfentanil, p-Fluorofentanyl, Fentanyl, ß-Hydroxyfentanyl, ß-Hydroxy-3-methylfentanyl, α-Methylfentanyl, α-Methylthiofentanyl, 3-Methylfentanyl, 3-Methylthiofentanyl, Remifentanil, Sufentanil, Thiofentanyl, 4-Anilino-N-phenethylpiperidine (ANPP), its derivatives and analogues and salts of derivatives and analogues
 

Including but not limited to fesoterodine fumarate.

Including but not limited to fingolimod hydrochloride.

For human use - except when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis.

For human use - when sold in a concentration of 150 mg per oral dosage unit and indicated for the treatment of vaginal candidiasis, in package sizes containing no more than 150 mg of fluconazole.

For veterinary use.

Including but not limited to flunixin meglumine.

For human use - in solid oral dosage forms containing more than 1 mg of fluoride ion.

Including but not limited to capecitabine, tegafur.

Including but not limited to flupentixol decanoate.

When sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing more than 360 metered sprays.

When sold for the treatment of allergic rhinitis in a nasal spray that delivers 50 mcg/spray for those 18 years of age and older, in package sizes containing no more than 360 metered sprays.

For human use - in oral dosage form containing more than 1.0 milligram of folic acid per dosage form or, where the largest recommended daily dosage shown on the label would, if consumed by a person, result in the daily intake by that person of more than 1.0 milligram of folic acid.

including but not limited to: follitropin alpha, follitropin beta, follitropin delta

For human use. 

For veterinary use

For human use.

For human use.

For human use.

Including but not limited to ganirelix acetate. 

Including but not limited to netilmicin.

except glycopyrronium bromide, including but not limited to glycopyrrolate, when used orally or for inhalation

Including but not limited to glycopyrrolate, when used orally or for inhalation.

Including but not limited to aurothioglucose, auranofin and sodium aurothiomalate, when sold for administration by injection.

For veterinary use.

For veterinary use

For human use.

For veterinary use.

For veterinary use.

For veterinary use - when sold or recommended for administration by intra-articular injection to horses.

For veterinary use.

When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in children under 2 years of age.

When sold in a concentration that provides 1% or less hydrocortisone in preparations for topical use on the skin in adults and children 2 years of age and over in package sizes containing more than 30 g.

When sold in a concentration less than or equal to 2% in preparations for topical use on the skin

When sold in a concentration greater than 2% in preparations for topical use on the skin.

When recommended as an antidote for cyanide poisoning.

Including but not limited to acenocoumarol when sold or recommended as anticoagulants.

Including but not limited to cetirizine and hydroxyzine hydrochloride. cetirizine or its salts when sold in concentration greater than 8.5 milligrams cetirizine per unit dose.

When recommended for parenteral use.

For human use - except when sold in an oral dosage form that provides 400 mg or less per dosage unit or in a modified-release oral dosage form that provides 600 mg or less per dosage unit.

For veterinary use.

when sold in a modified-release oral dosage form that provides 600 mg or less per dosage unit

Including but not limited to Icatibant acetate.

For human use: when sold or recommended to reduce the risk of cardiovascular events in statin-treated patients with elevated triglycerides.  

For veterinary use.

When recommended for sublingual use, including but not limited to: anthoxanthium odoratum L. (sweet vernal grass), betula verrucosa (white birch), dactylis glomerata L. (cocksfoot), lolium perenne L. (rye grass), phleum pratense L. (timothy grass), poa pratense L. (meadow grass).

For human use - except in preparations for topical use on the skin.

For veterinary use.

For veterinary use - including but not limited to ferumoxytol, for all routes of administration but parenteral.

For human use - including but not limited to ferumoxytol, iron isomaltoside 1000, for parenteral use only.

for use in the treatment of head lice

For human use.

For veterinary use

For human use - except in preparations for topical use as a shampoo.

when sold, a) for human use in oral dosage form at a concentration of more than 220 mg per dosage unit or per daily dose, as a single ingredient or in combination with other ingredients; or b) for human or veterinary use as a single ingredient intended for any route of administration other than oral

When recommended for parenteral use as a tissue sclerosing agent.

For human use - when sold for the treatment of hyperphosphatemia.

Including but not limited to teriflunomide. 

For human use. 

When sold for the treatment of primary or secondary levocarnitine deficiency.

For human use - when in a preparation containing an equal amount of tetracaine and recommended for topical use on the skin, in concentrations of 7% or higher.

for otic use

for topical use on the skin, including lozenges [except when in a preparation containing an equal amount of tetracaine and recommended for topical use on the skin, in concentrations of 7% or higher]

Including but not limited to: Clindamycin 

For human use. 

Including but not limited to Lodoxamide tromethamine.

For veterinary use.

Except in oral dosage form that provides 1 milligram (mg) or less per daily dose.

In injectable form for parenteral nutrition.

When sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.

Except when sold and recommended for use as a diagnostic agent for the assessment of bronchial hyperresponsiveness.

For human use.

For veterinary use - when sold to treat dogs only.

For veterinary use.

when sold in concentrations of 25 mg or less per dosage unit

For human use - when sold in concentrations greater than 25 mg per dosage unit.

For veterinary use - when sold for the treatment of heartworm in dogs.

For human use

Including: Acetylmethadol, Alphacetylmethadol, Alphamethadol, Betacetylmethadol, Betamethadol, Dimepheptanol, Noracymethadol
 

For veterinary use.

Including but not limited to methylnaltrexone bromide.

Including: Ethylphenidate; Isopropylphenidate; Propylphenidate; 3,4-Dichloromethylphenidate;  4-Methylmethylphenidate; 4-Fluoromethylphenidate; 
Methylnaphthidate; Ethylnaphthidate

For veterinary use

For veterinary use.

For human use - except in preparations for topical or vaginal.